AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹796 Cr | ₹949 Cr | ₹940 Cr | ₹595 Cr | ₹623 Cr |
What is the latest Total Current Liabilities ratio of AARTI DRUGS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹796 Cr |
Mar2023 | ₹949 Cr |
Mar2022 | ₹940 Cr |
Mar2021 | ₹595 Cr |
Mar2020 | ₹623 Cr |
How is Total Current Liabilities of AARTI DRUGS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹796 Cr | -16.21 | |
Mar2023 | ₹949 Cr | 1.00 | |
Mar2022 | ₹940 Cr | 57.90 | |
Mar2021 | ₹595 Cr | -4.47 | |
Mar2020 | ₹623 Cr | - |
Compare Total Current Liabilities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹3,594.9 Cr | -5.6% | -6.3% | -24.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -5.6% |
-6.3% |
-24.1% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses